The Epidemiological Profile of Non-Communicable Diseases in Jamaica: Burden, Transition, Social Patterning, Risk Factors, Health System Challenges, and Priorities for Prevention and Control

Abstract

Background: Non-communicable diseases (NCDs) constitute the dominant health burden in Jamaica and increasingly shape mortality, disability, health
expenditure, productivity, and demand for long-term health care. Although NCDs are extensively examined internationally, the Jamaican profile equires
integrated analysis because cardiovascular disease, hypertension, diabetes, cancer, obesity, chronic respiratory disease, chronic kidney disease (CKD), and their shared behavioural and social determinants coexist within a distinctive small-island developing-state context.
Objective: This study critically examines the epidemiological profile, temporal transition, determinants, inequalities, and policy implications of NCDs in Jamaica and comparatively situates the Jamaican experience within the Caribbean, the Americas, and the wider global NCD transition.
Methods: An integrative scholarly review synthesised national health surveys, Ministry of Health and Wellness reports, WHO and Pan American Health Organization (PAHO) surveillance, Jamaica Cancer Registry studies, population-based research, and peer-reviewed epidemiological literature. Evidence was comparatively examined across disease burden, mortality, hypertension, diabetes, obesity, cardiovascular risk, cancer, CKD, chronic respiratory disease, behavioural determinants, sex, age, socioeconomic position, and rurality.
Results: The evidence demonstrates a mature but evolving NCD epidemic. National studies document increasing adiposity, substantial hypertension and diabetes, considerable undiagnosed cardiometabolic disease, sex-specific risk patterns, and persistent behavioural risks. Overweight and obesity increased from 43.8% in 2000 to 55.5% in 2016, while contemporary PAHO estimates place overweight/obesity at 61.1%. Emerging evidence estimates CKD prevalence at approximately 15%, while cancer surveillance identifies prostate, breast, cervical, and colorectal malignancies as important components of the disease profile. NCD risk is consequently produced by interconnected demographic, behavioural, metabolic, socioeconomic, environmental, commercial, and health-system determinants.
Conclusion: Jamaica requires a transition from predominantly disease-specific NCD responses towards integrated life-course prevention, early detection, primary-care risk management, stronger surveillance, equity-sensitive intervention, and multisectoral regulation of the environments generating NCD risk.